After demonstrating that AOA reduces inflammation by inhibiting serine metabolism in Th17-mediated psoriasis, we investigated whether this drug could also reduce the inhibition of serine metabolism and IL-17A production in mouse primary Th17 cells. This evidence concerns the gene IL17A and psoriasis.